BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Jong Hwan Choi, Woo Jin Chung, Si Hyun Bae, Do Seon Song, Myeong Jun Song, Young Seok Kim, Hyung Joon Yim, Young Kul Jung, Sang Jun Suh, Jun Yong Park, Do Young Kim, Seung Up Kim, Sung Bum Cho. Randomized, prospective, comparative study on the effects and safety of sorafenib vs. hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosisCancer Chemotherapy and Pharmacology 2018; 82(3): 469 doi: 10.1007/s00280-018-3638-0
2
Hee Chul Nam, Pil Soo Sung, Ho Jong Chun, Dong Goo Kim, Jeong Won Jang, Jong Young Choi, Seung Kew Yoon. Liver Transplantation after Successful Downstaging with Hepatic Arterial Infusion Chemotherapy in a Patient with Hepatocellular Carcinoma with Portal Vein Tumor ThrombusJournal of Liver Cancer 2019; 19(1): 64 doi: 10.17998/jlc.19.1.64
3
Jui-Hu Hsiao, Cheng-Chung Tsai, Tsung-Jung Liang, Chia-Ling Chiang, Huei-Lung Liang, I-Shu Chen, Yu-Chia Chen, Po-Ming Chang, Nan-Hua Chou, Being-Whey Wang. Adjuvant hepatic arterial infusion chemotherapy is beneficial for selective patients with Hepatocellular carcinoma undergoing surgical treatmentInternational Journal of Surgery 2017; 45: 35 doi: 10.1016/j.ijsu.2017.07.071
4
Min Kyu Kang, Jung Gil Park, Heon Ju Lee. Comparison of clinical outcomes between sorafenib and hepatic artery infusion chemotherapy in advanced hepatocellular carcinomaMedicine 2018; 97(17): e0611 doi: 10.1097/MD.0000000000010611
5
Lipika Goyal, Motaz Qadan, Andrew X. Zhu. Another Treatment Option for Advanced Hepatocellular Carcinoma With Portal Vein Thrombosis in ChinaJAMA Oncology 2019; 5(7): 938 doi: 10.1001/jamaoncol.2019.0249
6
Masafumi Ikeda, Takuji Okusaka, Yozo Sato, Junji Furuse, Shuichi Mitsunaga, Hideki Ueno, Chigusa Morizane, Yoshitaka Inaba, Tatsushi Kobayashi, Yasuaki Arai. A Phase I/II trial of continuous hepatic intra-arterial infusion of 5-fluorouracil, mitoxantrone and cisplatin for advanced hepatocellular carcinomaJapanese Journal of Clinical Oncology 2017; 47(6): 512 doi: 10.1093/jjco/hyx038
7
Elena Fountzilas, Elangovan Krishnan, Filip Janku, Siqing Fu, Daniel D. Karp, Aung Naing, Vivek Subbiah, David S. Hong, Sarina A. Piha-Paul, David J. Vining, Apostolia-Maria Tsimberidou. A phase I clinical trial of hepatic arterial infusion of oxaliplatin and oral capecitabine, with or without intravenous bevacizumab, in patients with advanced cancer and predominant liver involvementCancer Chemotherapy and Pharmacology 2018; 82(5): 877 doi: 10.1007/s00280-018-3680-y
8
Michael Hsu, Muneeb Ahmed, Ammar Sarwar. Indications and Best Practices for Intra-arterial Therapies to Treat Hepatocellular CarcinomaCurrent Hepatology Reports 2018; 17(4): 399 doi: 10.1007/s11901-018-0428-4
9
Ziyou Wang, Hua Zhang, Jiahui Zhou, Xiangning Zhang, Liyong Chen, Kangxing Chen, Zunnan Huang. Eriocitrin from lemon suppresses the proliferation of human hepatocellular carcinoma cells through inducing apoptosis and arresting cell cycleCancer Chemotherapy and Pharmacology 2016; 78(6): 1143 doi: 10.1007/s00280-016-3171-y
10
Antitumor Effects of Intra-Arterial Delivery of Albumin-Doxorubicin Nanoparticle Conjugated Microbubbles Combined with Ultrasound-Targeted Microbubble Activation on VX2 Rabbit Liver TumorsCancers 2019; 11(4): 581 doi: 10.3390/cancers11040581
11
Clifford Akateh, Sylvester M Black, Lanla Conteh, Eric D Miller, Anne Noonan, Eric Elliott, Timothy M Pawlik, Allan Tsung, Jordan M Cloyd. Neoadjuvant and adjuvant treatment strategies for hepatocellular carcinomaWorld Journal of Gastroenterology 2019; 25(28): 3704-3721 doi: 10.3748/wjg.v25.i28.3704
12
Kazuya SASAKI, Toshiki SAKAMOTO, So MATSUI, Misao SAITO. Multiple Early Intrahepatic Recurrences of Hepatocellular Carcinoma after Hepatectomy Successfully Treated by Hepatic Arterial ChemotherapyNihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) 2018; 79(7): 1506 doi: 10.3919/jjsa.79.1506
13
Taro Takami, Takahiro Yamasaki, Issei Saeki, Toshihiko Matsumoto, Yutaka Suehiro, Isao Sakaida. Supportive therapies for prevention of hepatocellular carcinoma recurrence and preservation of liver functionWorld Journal of Gastroenterology 2016; 22(32): 7252-7263 doi: 10.3748/wjg.v22.i32.7252
14
Fangmin Chen, Yifan Fang, Ruirui Zhao, Jingqing Le, Bingchen Zhang, Rui Huang, Zixuan Chen, Jingwei Shao. Evolution in medicinal chemistry of sorafenib derivatives for hepatocellular carcinomaEuropean Journal of Medicinal Chemistry 2019; 179: 916 doi: 10.1016/j.ejmech.2019.06.070